Nutra Pharma Corp. Stock Other OTC
Equities
NPHC
US67060U2087
Biotechnology & Medical Research
Sales 2020 | 51.9K 70.81K | Sales 2021 | 97.74K 133K | Capitalization | 14.65M 19.99M |
---|---|---|---|---|---|
Net income 2020 | - 0 | Net income 2021 | -13M -17.74M | EV / Sales 2020 | 238 x |
Net Debt 2020 | 5.24M 7.15M | Net Debt 2021 | 8.3M 11.33M | EV / Sales 2021 | 235 x |
P/E ratio 2020 |
-10.3
x | P/E ratio 2021 |
-1.1
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 62 | 16-07-26 | |
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 02-11-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 02-11-06 |
Stewart Lonky
BRD | Director/Board Member | 75 | 04-11-04 |
Garry Pottruck
BRD | Director/Board Member | 65 | 09-07-28 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+48.09% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |